Search

You searched for "email"

1158 results found

Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium

18 September 2023 | Glaucoma, CID, Ciliatech, Research
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.

New YouGov data reveals that 2/3 British adults support greater use of independent health providers to cut waiting times

10 November 2023 | insourcing, NHS, waiting lists, private sector, labour party, YouGov
New YouGov data reveals that two-thirds of British adults support greater use of independent health providers to cut waiting times amid cross-party calls for NHS reform.

A European ophthalmology perspective

1 October 2014 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
Europe: from the Greek eurus: broad, wide, and ops: eye, face, sight. Thus Europe = the far-sighted (lady). For my first contribution to this column – as the successor of Jonathan Park, whose witty observations and entertaining style many of...

The Worshipful Company Of Spectacle Makers closes 2023 with 9 new liverymen and 1 new court assistant

12 January 2024 | awards, organisation, healthcare professional, allied professions, livery, collaboration
The Worshipful Company of Spectacle Makers brought a successful 2023 to a close with the admission of 9 new Liverymen at its December Court Lunch.

Post-stroke visual impairment: how big is the problem, how do we identify it, what we can do about it, and why does it matter?

1 December 2022 | | Ophthalmology
In the UK, 100,000 new strokes occur each year, with 1.3 million stroke survivors [1]. This article will focus on post-stroke visual impairment, discussing topics of how common it is, how it can be detected, possible management options and how...

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

4 August 2021 | | Ophthalmology, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...

Do patient demographics influence AMD clinic attendance during COVID-19 lockdown?

3 June 2021 | | COVID-19, Ophthalmology, Retina / Uvea / Vitreous
The authors assess the impact of the COVID-19 pandemic on adherence to scheduled clinic appointments among age-related macular degeneration patients in a clinic in North Wales. The COVID-19 pandemic has significantly affected the population, affecting economic and social wellbeing, whilst...

Addressing medical risk factors for diabetes and understanding the new systemic treatments

1 February 2014 |
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...

A career in uveitis

7 December 2020 | | Ophthalmology, Retina / Uvea / Vitreous
As he retires from clinical practice, the author looks back on his long career in uveitis and how care of these patients has changed dramatically since his days as an undergraduate. My trainees and fellows are often bored by my...

Corporate M&A pace gathers momentum

1 October 2019 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

Technology in ophthalmology – a promising future and what we need to know about the regulations

1 October 2017 | | Cataract and Refractive, Cornea / External Eye Disease, Glaucoma, Imaging, Ophthalmology, Optometry, Orbit, Retina / Uvea / Vitreous, AMD
Undoubtedly, ophthalmology is one of the greatest sources of inspiration for technological progress in medicine. Thus far, we have seen remarkable advancements in the technology used by ophthalmologists across all subspecialties. From simplifying common procedures, to treating previously incurable conditions,...

Investigating the link between corneal clarity and statin use

2 February 2024 | | Cornea / External Eye Disease
Transparency is a vital attribute of the cornea, necessary in preserving healthy vision. Maintaining this requires the collective input of the various layers of the cornea. Mostly, the layers implicated in this are the corneal stroma and endothelium [1]. Our...